Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00942045 · ClinicalTrials.gov registry record
Osteocel® Plus in Anterior Cervical Discectomy and Fusion (ACDF)
A clinical trial, sponsored by NuVasive.
- Completed
- Registry status
- 182
- Enrollment target
NCT00942045: Completed study, sponsored by NuVasive.
NCT00942045 is a clinical trial that has completed, run by NuVasive. The registered enrollment target is 182 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00942045 has completed, sponsored by NuVasive.
- COMPLETED
- Registry status
- 182 participants
- Enrollment target
Study Summary
This is a prospective, non-randomized multi-center study to compare the use of Osteocel Plus in subjects who receive ACDF surgery at one or two levels. These subjects will present with degenerative conditions in the cervical spine that are amenable to surgical treatment and will be screened prior to study enrollment. Subjects will receive Osteocel Plus, without any other biologic product, during their ACDF operation. The ACDF procedure will be conducted with a radiolucent graft containment device such that progression of fusion can be adequately assessed via radiograph. Subjects will be followed for 24-months following surgery to determine the number of study subjects that are solidly fused at or before 24 months postoperatively, and to determine the mean time to fusion. This data will be compared to published and/or retrospective data for autograft, synthetic ceramics and Bone Morphogenetic Protein (BMP).
Interventions
- BIOLOGICAL Biologic - Osteocel Plus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2009-02 |
| Est. Completion | 2012-10 |
What the finished NCT00942045 record still lists
NCT00942045 is an observational study that tracks outcomes without assigning an intervention. The registered 182 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Biologic - Osteocel Plus is the first listed.
NCT00942045 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00942045 about?
NCT00942045 is a clinical study titled "Osteocel® Plus in Anterior Cervical Discectomy and Fusion (ACDF)". This is a prospective, non-randomized multi-center study to compare the use of Osteocel Plus in subjects who receive ACDF surgery at one or two levels. These subjects will present with degenerative conditions in the cervical spine that are amenable to surgical treatment and will be screened prior to...
What is the current status of trial NCT00942045?
This trial is currently completed. The enrollment target is 182 participants. The study started on 2009-02. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00942045?
The interventions under investigation include: Biologic - Osteocel Plus (BIOLOGICAL).
Who is sponsoring clinical trial NCT00942045?
This trial is sponsored by NuVasive, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03897998 · 182 participants · Phase 2
Neural Correlates of Hypoalgesia Driven by Observation
- NCT04300556 · 182 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- NCT04323735 · 182 participants · Phase 2
Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters
- NCT05606731 · 182 participants · NA
Family Intervention to Prevent Childhood Obesity
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia